Search
Metastatic Breast Cancer Clinical Trials in Canada
A listing of 8 Metastatic Breast Cancer clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 8 of 8
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Metastatic Breast Cancer
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
There are currently 8 active clinical trials seeking participants for Metastatic Breast Cancer research studies. The states with the highest number of trials for Metastatic Breast Cancer participants are .
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
Recruiting
The purpose of this study is to assess the efficacy and safety of belzutifan (MK-6482) plus fulvestrant compared to everolimus plus endocrine therapy (ET) (investigator's choice of fulvestrant or exemestane) in adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) unresectable metastatic breast cancer. There is no formal hypothesis testing in this study.
The purpose of this study is to assess the efficacy and safety of belzutifan (MK-6482) plus fulvestrant compared to everolimus plus endocrine therapy (ET) (investigator's choice of fulvestrant or exemestane) in adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) unresectable metastatic breast cancer. There is no formal hypothesis testing in this study. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/12/2025
Locations: City of Hope - Phoenix ( Site 0006), Goodyear, Arizona +36 locations
City of Hope - Phoenix ( Site 0006), Goodyear, Arizona
Cedars Sinai Medical Center ( Site 0012), Beverly Hills, California
Moores Cancer Center at UC San Diego Health ( Site 0025), La Jolla, California
USC/Norris Comprehensive Cancer Center ( Site 0013), Los Angeles, California
USC Norris Oncology Hematology Newport Beach ( Site 0029), Newport Beach, California
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0011), Marietta, Georgia
Southeastern Regional Medical Center ( Site 0010), Newnan, Georgia
CHRISTUS Highland ( Site 0005), Shreveport, Louisiana
Renown Regional Medical Center ( Site 0018), Reno, Nevada
MD Anderson ( Site 0015), Houston, Texas
Mays Cancer Center ( Site 0022), San Antonio, Texas
Centro de Investigaciones Metabólicas (CINME)-Oncology ( Site 0504), Caba, Buenos Aires
Hospital Británico de Buenos Aires-Oncology ( Site 0500), Ciudad autónoma de Buenos Aires, Buenos Aires
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0502), Mar del Plata, Buenos Aires
Instituto Alexander Fleming-Alexander Fleming ( Site 0505), Ciudad Autónoma de Buenos Aires, Caba
Sanatorio Allende - Cerro-Oncology ( Site 0506), Córdoba, Cordoba
Instituto de Oncología de Rosario ( Site 0501), Rosario, Santa Fe
Jewish General Hospital ( Site 0400), Montreal, Quebec
Centro de Investigación del Maule ( Site 4106), Talca, Maule
Bradfordhill ( Site 4100), Santiago., Region M. De Santiago
FALP ( Site 4102), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile ( Site 4108), Santiago, Region M. De Santiago
IMAT S.A.S ( Site 1205), Monteria, Cordoba
Oncologos Del Occidente ( Site 1200), Pereira, Risaralda
Fundacion Valle del Lili ( Site 1204), Cali, Valle Del Cauca
Seoul National University Hospital ( Site 3100), Seoul, Not set
Samsung Medical Center ( Site 3101), Seoul, Not set
National Cheng Kung University Hospital ( Site 3300), Tainan, Not set
National Taiwan University Hospital ( Site 3301), Taipei, Not set
National Taiwan University Cancer Center ( Site 3302), Taipei, Not set
Faculty of Medicine - Khon Kaen University ( Site 3502), Muang, Khon Kaen
Faculty of Medicine Siriraj Hospital ( Site 3500), Bangkoknoi, Krung Thep Maha Nakhon
Songklanagarind Hospital ( Site 3501), Hat Yai, Songkhla
The Royal Cornwall Hospital ( Site 1904), Truro, England
St Bartholomews Hospital ( Site 1900), London, London, City Of
The Christie Hospital NHS Foundation Trust ( Site 1902), Withington, Manchester
Ipswich Hospital ( Site 1911), Ipswich, Suffolk
Conditions: Metastatic Breast Cancer
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Recruiting
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer.
Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are f... Read More
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer.
Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2.
This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them.
This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®.
This study will test how safe and how well DV with tucatinib works for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/06/2025
Locations: Banner-University Medical Center Tucson Campus, Tucson, Arizona +122 locations
Banner-University Medical Center Tucson Campus, Tucson, Arizona
Banner-University Medical Center Tucson Campus, Tucson, Arizona
Banner-University Medical Center Tucson, Tucson, Arizona
The University of Arizona Cancer Center-North Campus Pharmacy, Attn: Kelly Myrdal, Tucson, Arizona
University of Arizona Cancer Center - North Campus, Tucson, Arizona
The University of Arizona Cancer Center-Main, Tucson, Arizona
UC Irvine Medical Center, Orange, California
University of California, San Francisco | HDFCCC - Hematopoietic Malignancies, San Francisco, California
UCLA Department of Medicine - Hematology & Oncology, Santa Monica, California
Colorado West Healthcare System, dba Community Hospital, Grand Junction, Colorado
Colorado West Healthcare, dba Grand Valley Oncology, Grand Junction, Colorado
Danbury Hospital, Danbury, Connecticut
The Whittingham Cancer Center / Norwalk Hospital, Norwalk, Connecticut
Georgetown University Medical Center, Washington, District of Columbia
MedStar Georgetown University Hospital, Washington, District of Columbia
Moffitt Cancer Center - International Plaza, Tampa, Florida
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
Moffitt Cancer Center - McKinley Campus, Tampa, Florida
Moffitt McKinley Hospital, Tampa, Florida
Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida
Georgia Cancer Specialists - Athens, Athens, Georgia
Georgia Cancer Specialists - Annex, Atlanta, Georgia
Atlanta Cancer Care - Atlanta, Atlanta, Georgia
Georgia Cancer Specialists-Northside, Atlanta, Georgia
Northside Hospital, Inc.- Central Research Department, Atlanta, Georgia
Northside Hospital, Atlanta, Georgia
Georgia Cancer Specialists - Blairsville, Blairsville, Georgia
Georgia Cancer Specialists - Canton, Canton, Georgia
Atlanta Cancer Care - Cumming, Cumming, Georgia
Georgia Cancer Specialists - Cumming, Cumming, Georgia
Georgia Cancer Specialists - Decatur, Decatur, Georgia
Suburban Hematology-Oncology Associates - Duluth, Duluth, Georgia
Suburban Hematology-Oncology Associates- Lawrenceville, Lawrenceville, Georgia
Georgia Cancer Specialists - Macon, Macon, Georgia
Georgia Cancer Specialists - Marietta, Marietta, Georgia
Memorial Hospital, Shiloh, Illinois
Siteman Cancer Center - Shiloh, Shiloh, Illinois
Massachusetts General Hospital., Boston, Massachusetts
Brigham and Women's Hospital, Boston, Massachusetts
Dana Farber Cancer Institute, Boston, Massachusetts
Dana Farber Cancer Institute- Chestnut Hill, Newton, Massachusetts
Siteman Cancer Center - West County, Creve Coeur, Missouri
Siteman Cancer Center - North County, Florissant, Missouri
Saint Luke's Cancer Institute LLC, Kansas City, Missouri
Saint Luke's Hospital Investigational Pharmacy, Kansas City, Missouri
St Lukes Hospital, Kansas City, Missouri
Barnes-Jewish Hospital, Saint Louis, Missouri
Washington University in St Louis., Saint Louis, Missouri
Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri
Siteman Cancer Center - South County, Saint Louis, Missouri
Siteman Cancer Center - St Peters, Saint Peters, Missouri
Renown Regional Medical Center, Reno, Nevada
San Juan Oncology Associates, Farmington, New Mexico
Memorial Sloan Kettering Cancer Center - Main Hospital, New York, New York
Zangmeister Cancer Center, Columbus, Ohio
Saint Francis Hospital / Bon Secours - South Carolina, Greenville, South Carolina
Sarah Cannon Research Institute - Pharmacy, Nashville, Tennessee
SCRI Oncology Partners, Nashville, Tennessee
Tennessee Oncology-Nashville/Sarah Cannon Research Institute, Nashville, Tennessee
Parkland Health and Hospital System, Dallas, Texas
University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas, Texas
University of Texas Southwestern Medical Center-Simmons Cancer Center Pharmacy, Dallas, Texas
University of Texas Southwestern Medical Center Simmons Cancer Center - Redbird, Dallas, Texas
University of Texas Southwestern Medical Center Clinical Lab-Zale Lipshy University Hospital, Dallas, Texas
University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas, Texas
University of Texas Southwestern Medical Center, Dallas, Texas
University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth, Texas
University of Texas Southwestern Medical Center Simmons Cancer Center - Richardson/Plano, Richardson, Texas
Harborview Medical Center, Seattle, Washington
Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington, Seattle, Washington
University of Washington Medical Center, Seattle, Washington
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin
Carbone Cancer Center / University of Wisconsin, Madison, Wisconsin
Peninsula & South Eastern Hematology and Oncology Group (PASO), Frankston, Victoria
Slade Pharmacy Frankston, Frankston, Victoria
Slade Health, Mount Waverley, Victoria
Peninsula & South Eastern Hematology and Oncology Group (PASO), Frankston, Not set
BC Cancer Kelowna., Kelowna, British Columbia
Ottawa Hospital Cancer Centre, Ottawa, Ontario
Sunnybrook Health Sciences Centre, Toronto, Ontario
University Health Network, Princess Margaret Hospital, Toronto, Ontario
Universitatsklinikum Essen, Essen, Not set
Universitatsklinikum Heidelberg, Heidelberg, Not set
Klinikums rechts der Isar der TU München, Muenchen, Not set
A.O.U. Federico II, Napoli, Campania
Azienda Ospedaliera Universitaria (AOU) Federico II, Napoli, Campania
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale., Napoli, Campania
Istituto Europeo di Oncologia, Milano, Lombardia
Niguarda Ca' Granda Hospital, Milano, Lombardia
Humanitas Istituto Clinico Catanese, Misterbianco (CT), Sicilia
Azienda Ospedaliera Universitaria Integrata di Verona., Verona, Veneto
A.O.U. Federico II- U.O.C. Diagnostica per lmmagini e Radioterapia, Napoli, Not set
Dong-A University Hospital, Busan, Other
National Cancer Center, Goyang-si, Other
Chungbuk National University Hospital, Cheongju-si, Not set
Gachon University Gil Medical Center, Incheon, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Korea University Anam Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
St. Vincent's Hospital, The Catholic University of Korea, Suwon-si, Not set
Quirén Salud Barcelona, Barcelona, Not set
Hospital Universitari Vall d´Hebron, Barcelona, Not set
CETIR Grup Medic, Barcelona, Not set
Hospital Universitario de Basurto, Bilbao, Not set
Grupo Hospitalario QuironSalud, Erandio Bizkaia, Not set
L'Institut Catala d'Oncologia., L'Hospitalet de Llobregat, Not set
Farmacia-Ensayos. Planta S - Hospital Universitario HM Sanchinarro-CIOCC-START Madrid, Madrid, Not set
START Madrid-CIOCC_Hospital HM Sanchinarro, Madrid, Not set
Ecg Medica Sl, Valencia, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
National Taiwan University Hospital, Taipei, Not set
National Taiwan University Cancer Center, Taipei, Not set
The Royal Marsden Hospital, Sutton, Surrey
St Bartholomew's Hospital, London, Not set
The Royal Marsden Hospital, London, Not set
The Royal Marsden NHS Foundation Trust (RM), London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
The Royal Marsden NHS Foundation Trust, Sutton, Not set
Conditions: Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast Cancer, Advanced Gastric Cancer
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Recruiting
This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with placebo in combination with Phesgo, as maintenance therapy, after induction therapy in participants with previously untreated HER2-positive advanced breast cancer (ABC).
This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with placebo in combination with Phesgo, as maintenance therapy, after induction therapy in participants with previously untreated HER2-positive advanced breast cancer (ABC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: Banner Health MD Anderson AZ, Gilbert, Arizona +174 locations
Banner Health MD Anderson AZ, Gilbert, Arizona
Disney Family Cancer Center, Burbank, California
Ellison Institute of Technology, Los Angeles, California
Georgetown Uni Hospital, Washington, District of Columbia
Medstar Research Institute, Hyattsville, Maryland
Dana Farber Cancer Institute, Boston, Massachusetts
Henry Ford Hospital, Detroit, Michigan
Renown Regional Medical Center, Reno, Nevada
Hackensack University Medical Center, Hackensack, New Jersey
Atrium Health, Charlotte, North Carolina
Hightower Clinical, Oklahoma City, Oklahoma
Renovatio Clinical - El Paso, El Paso, Texas
JPS Health Network, Fort Worth, Texas
Lumi Research, Kingwood, Texas
Renovatio Clinical, The Woodlands, Texas
Kadlec Clinic Hematology and Oncology, Kennewick, Washington
Swedish Medical Center, Seattle, Washington
Fundación CENIT para la Investigación en Neurociencias, Buenos Aires, Not set
Centro Oncologico Korben, Ciudad Autonoma Buenos Aires, Not set
Instituto de Oncología de Rosario, Rosario, Not set
Hospital Provincial del Centenario, Rosario, Not set
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica, San Juan, Not set
Clínica Viedma, Viedma Rio Negro, Not set
Blacktown Hospital, Blacktown, New South Wales
Kinghorn Cancer Centre, Darlinghurst, New South Wales
Gosford Hospital, Gosford, New South Wales
University of the Sunshine Coast, Sippy Downs, Queensland
Monash Health, Clayton, Victoria
Sir Charles Gairdner Hospital, Perth, Western Australia
Cliniques Universitaires St-Luc, Bruxelles, Not set
GHdC Site Les Viviers, Charleroi, Not set
Jessa Zkh (Campus Virga Jesse), Hasselt, Not set
Clinique Ste-Elisabeth, Namur, Not set
Hospital Sao Rafael - HSR, Salvador, Bahia
Crio - Centro Regional Integrado de Oncologia, Fortaleza, Ceará
Hospital Araujo Jorge, Goiania, Goiás
Hospital do Câncer de Londrina, Londrina, Paraná
Hospital do Cancer de Pernambuco - HCP, Recife, Pernambuco
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul
Hospital Sao Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul
Hospital de Amor Amazônia, Porto Velho, Rondônia
Hospital de Cancer de Barretos, Barretos, São Paulo
Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, Sao Paulo, São Paulo
Arthur J.E. Child Comprehensive Cancer Center-Calgary, Calgary, Alberta
The Moncton Hospital, Moncton, New Brunswick
Eastern Health - General Hospital, St. John's, Newfoundland and Labrador
Sunnybrook Health Sciences Centre, Toronto, Ontario
Centre Hospitalier de l?Université de Montréal (CHUM), Montreal, Quebec
Jewish General Hospital, Montreal, Quebec
Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec
Hopital du Saint Sacrement, Quebec City, Quebec
Allan Blair Cancer Center, Regina, Saskatchewan
Affiliated Hospital of Hebei University, Baoding, Not set
Beijing Cancer Hospital, Beijing, Not set
The First Hospital of Jilin University, Changchun City, Not set
Sichuan Provincial Cancer Hospital, Chengdu, Not set
Sichuan Provincial People's Hospital, Chengdu, Not set
Fujian Cancer Hospital, Fuzhou, Not set
Zhejiang Cancer Hospital, Hangzhou City, Not set
Harbin Medical University Tumor Hospital, Harbin, Not set
Shandong Cancer Hospital, Jinan, Not set
The First Affiliated Hospital to Henan University of Science and Technology, Luoyang, Not set
The Second Affiliated Hospital to Nanchang University, Nanchang, Not set
Guangxi Cancer Hospital of Guangxi Medical University, Nanning, Not set
Shantou Center Hospital, Shantou City, Not set
Tianjin Cancer Hospital, Tianjin, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan City, Not set
Hubei Cancer Hospital, Wuhan, Not set
Clinica De La Costa, Barranquilla, Not set
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C., Not set
Oncomedica S.A., Monteria, Not set
Sociedad de Oncología y hematología del Cesar Ltda, Valledupar, Not set
Tampere University Hospital, Tampere, Not set
Turku Uni Central Hospital, Turku, Not set
Institut Sainte Catherine, Avignon, Not set
Centre Hospitalier de La Cote Basque, Bayonne, Not set
Polyclinique Bordeaux Nord Aquitaine, Bordeaux, Not set
Centre Georges Francois Leclerc, Dijon, Not set
Centre Oscar Lambret, Lille, Not set
Klinikum St. Marien, Amberg, Not set
HELIOS Klinikum Berlin-Buch, Berlin, Not set
Marienhospital Bottrop gGmbH, Bottrop, Not set
Gynonco Düsseldorf, MVZ Medical Center GmbH, Düsseldorf, Not set
Frauenarztpraxis Dr. Apel, Dr. Kolpin, Erfurt, Not set
Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, Freiburg, Not set
Klinik & Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt, München, Not set
St. Franziskus Hospital Münster;Studiensekretariat der onkologischen Zentren, Münster, Not set
Caritas Klinik St. Theresia -Frauenklinik Brustzentrum, Saarbruecken, Not set
Gynäkologie Kompetenzzentrum, Stralsund, Not set
Universitätsfrauenklinik Ulm, Ulm, Not set
Queen Mary Hospital, Hong Kong, Not set
Tuen Mun Hospital, Hong Kong, Not set
Max Super Speciality Hospital, NEW Delhi Delhi, Delhi
Gujarat Cancer & Research Inst., Ahmadabad CITY, Gujarat
Sunshine Global Hospital (A unit of Baroda Medicare Pvt Ltd), Surat CITY, Gujarat
Artemis Hospital, Gurugram, Haryana
Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra
National Cancer Institute, Nagpur, Maharashtra
Tata Medical Center, Kolkata, WEST Bengal
I.R.S.T Srl IRCCS, Meldola, Emilia-Romagna
Ospedale San Giovanni Addolorata, Roma, Lazio
Ospedale San Raffaele, Milano, Lombardia
Irccs Istituto Nazionale Dei Tumori (Int), Milano, Lombardia
Irccs Istituto Europeo Di Oncologia (IEO), Milano, Lombardia
Ospedale San Gerardo, Monza, Lombardia
A.O.U. Maggiore della Carità, Novara, Piemonte
Casa di Cura La Maddalena, Palermo, Sicilia
Ospedale Santa Maria Annunziata, Bagno a Ripoli, Toscana
"Azienda Ospedaliera Universitaria Integrata Verona Ospedale Borgo Trento", Verona, Veneto
King Hussein Cancer Center, Amman, Not set
University of Nairobi - Institute of Tropical and Infectious Diseases, Nairobi, Not set
National Cancer Center, Goyang-si, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Seoul St Mary's Hospital, Seoul, Not set
Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco
OncoMed, Ciudad de México, Mexico CITY (federal District)
Centro Oncológico Hematológico Roma, Mexico City, Mexico CITY (federal District)
Hospital Universitario, Monterrey, Nuevo LEON
CENEIT Oncologicos, Mexico City, Not set
Sultan Qaboos Comprehensive Cancer Care & Research Center, Muscat, Not set
Centrum Onkologii im. Prof. Franciszka ?ukaszczyka, Bydgoszcz, Not set
Uniwersyteckie Centrum Kliniczne, Gda?sk, Not set
Szpital Morski im.PCK, Gdynia, Not set
Narodowy Instytut Onkologii Odzia? w Gliwicach, Gliwice, Not set
Przychodnia Lekarska KOMED, Roman Karaszewski, Konin, Not set
Szpital Wojewódzki im. Miko?aja Kopernika, Koszalin, Not set
Wielkopolskie Centrum Onkologii im. Marii Sk?odowskiej-Curie, Pozna?, Not set
Centrum Onkologii Instytut im.M. Sklodowskiej-Curie, Warszawa, Not set
National University Hospital, Singapore, Not set
National Cancer Centre, Singapore, Not set
Icon Cancer Centre Farrer Park, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Hopelands Cancer Centre, Hilton, Not set
Charlotte Maxeke Academic Hospital, Johannesburg, Not set
Medical Oncology Centre of Rosebank, Johannesburg, Not set
Limpopo Cancer Research Institute, Polokwane, Not set
Steve Biko Academic Hospital, Pretoria, Not set
Chris Hani Baragwanath Clinical Trial Site, Soweto, Not set
Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña, LA Coruna
Hospital Universitari Dexeus - Grupo Quironsalud, Barcelona, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Ramon y Cajal, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Clinico Universitario Virgen de la Victoria, Malaga, Not set
Hospital Universitario Virgen Macarena, Sevilla, Not set
National Taiwan Uni Hospital, Taipei, Not set
Tri-Service General Hospital, Taipei, Not set
Chang Gung Memorial Hospital-Linkou, Taoyuan County, Not set
Abderrahmen Mami Hospital, Ariana, Not set
Taher Maamouri Hospital, Nabeul, Not set
Habib Bourguiba Hospital, Sfax, Not set
Farhat Hached Hospital, Sousse, Not set
Institut Salah Azeiz, Tunis, Not set
Sakarya Training and Research Hospital, Adapazar?, Not set
Gulhane Training and Research Hospital, Ankara, Not set
Gazi University Medical Faculty, Ankara, Not set
Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Tibbi Onkoloji, Bakirkoy / Istanbul, Not set
Dicle University Faculty of Medicine, Diyarbakir, Not set
Medipol Mega Üniversite Hastanesi Göztepe, Istanbul, Not set
Katip Celebi University Ataturk Training and Research Hospital, Izmir, Not set
Medical Park Seyhan Hospital, Seyhan, Not set
Hacettepe Uni Medical Faculty Hospital, Sihhiye/Ankara, Not set
Uganda Cancer Institute, Kampala, Not set
Belfast City Hospital, Belfast, Not set
Blackpool Victoria Hospital, Blackpool, Not set
Colchester General Hospital, Colchester, Essex, Not set
Mount Vernon Hospital, Northwood, Not set
Nottingham City Hospital, Nottingham, Not set
Churchill Hospital, Oxford, Not set
Conditions: Metastatic Breast Cancer
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Recruiting
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
07/22/2025
Locations: Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario, Kingston, Ontario +1 locations
Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario, Kingston, Ontario
Sunnybrook Health Sciences Centre, Toronto, Ontario
Conditions: Metastatic Breast Cancer
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
Recruiting
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-free survival (PFS) by blinded independent central review (BICR) in the HR+, HER2-low (immunohistochemistry \[IHC\]2+/in situ hybridization \[ISH\]- and IHC 1+) population.
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-free survival (PFS) by blinded independent central review (BICR) in the HR+, HER2-low (immunohistochemistry \[IHC\]2+/in situ hybridization \[ISH\]- and IHC 1+) population. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/16/2025
Locations: Research Site 1141-0, Tucson, Arizona +252 locations
Research Site 1141-0, Tucson, Arizona
Research Site 1114-0, Fullerton, California
Research Site 1107-0, Los Angeles, California
Research Site 1118-0, Orange, California
Research Site 1143-0, Sacramento, California
Research Site 1132-0, Santa Barbara, California
Research Site 1137-0, Aurora, Colorado
Research Site 1129-0, Lone Tree, Colorado
Research Site 1154-0, Jacksonville, Florida
Research Site 1145-0, Miami, Florida
Research Site 1150-0, Orange City, Florida
Research Site 1125-0, Palm Bay, Florida
Research Site 1110-0, Savannah, Georgia
Research Site 1124-0, Chicago Ridge, Illinois
Research Site 1147-0, Chicago, Illinois
Research Site 1152-0, Fort Wayne, Indiana
Research Site 1106-0, Merriam, Kansas
Research Site 1104-0, Louisville, Kentucky
Research Site 1122-0, Silver Spring, Maryland
Research Site 8639-0, Silver Spring, Maryland
Research Site 1109-0, Kansas City, Missouri
Research Site 1111-0, Florham Park, New Jersey
Research Site 1157-0, Santa Fe, New Mexico
Research Site 1148-0, Staten Island, New York
Research Site 1105-0, Westbury, New York
Research Site 1144-0, Chapel Hill, North Carolina
Research Site 1138-0, Akron, Ohio
Research Site 1160-0, Cincinnati, Ohio
Research Site 1133-0, Eugene, Oregon
Research Site 1126-0, Tigard, Oregon
Research Site 1134-0, Broomall, Pennsylvania
Research Site 1123-0, Horsham, Pennsylvania
Research Site 1149-0, Knoxville, Tennessee
Research Site 1102-0, Nashville, Tennessee
Research Site 1101-0, Dallas, Texas
Research Site 1116-0, Denison, Texas
Research Site 1115-0, Houston, Texas
Research Site 1117-0, San Antonio, Texas
Research Site 1130-0, Salt Lake City, Utah
Research Site 1108-0, Fairfax, Virginia
Research Site 1131-0, Fairfax, Virginia
Research Site 1127-0, Roanoke, Virginia
Research Site 5411-0, Bahia Blanca, Buenos Aires
Research Site 5414-0, Caba, Buenos Aires
Research Site 5405-0, La Plata, Buenos Aires
Research Site 5413-0, Mar del Plata, Buenos Aires
Research Site 5408-0, Quilmes, Buenos Aires
Research Site 5403-0, Caba, Ciudad Autonoma Buenos Aires
Research Site 5402-0, Viedma, Rio Negro
Research Site 5401-0, Rosario, Santa Fe
Research Site 5406-0, Rosario, Santa Fe
Research Site 5404-0, San Miguel de Tucuman, Tucuman
Research Site 5407-0, Ciudad Autonoma Buenos Aires, Not set
Research Site 5409-0, Ciudad Autonoma Buenos Aires, Not set
Research Site 6108-0, Camperdown, New South Wales
Research Site 6116-0, Kingswood, New South Wales
Research Site 6109-0, Liverpool, New South Wales
Research Site 6102-0, Sydney, New South Wales
Research Site 6106-0, Birtinya, Queensland
Research Site 6101-0, South Brisbane, Queensland
Research Site 6107-0, Southport, Queensland
Research Site 6104-0, Townsville, Queensland
Research Site 6110-0, Adelaide, South Australia
Research Site 6103-0, Bendigo, Victoria
Research Site 6105-0, St. Albans, Victoria
Research Site 6113-0, Traralgon, Victoria
Research Site 6114-0, Perth, Western Australia
Research Site 3201-0, Brussels, Not set
Research Site 3204-0, Gent, Not set
Research Site 3205-0, Jette, Not set
Research Site 3203-0, Leuven, Not set
Research Site 3207-0, Liege, Not set
Research Site 3202-0, Roeselare, Not set
Research Site 1007-0, Winnipeg, Manitoba
Research Site 1003-0, Brampton, Ontario
Research Site 1001-0, Toronto, Ontario
Research Site 1004-0, Montreal, Quebec
Research Site 1005-0, Montreal, Quebec
Research Site 1006-0, Montreal, Quebec
Research Site 1002-0, Sherbrooke, Quebec
Research Site 8640-0, Hefei, Anhui
Research Site 8614-0, Hefei, Anhui
Research Site 8601-0, Beijing, Beijing
Research Site 8625-0, Beijing, Beijing
Research Site 8653-0, Beijing, Beijing
Research Site 8627-0, Chongqing, Chongqing
Research Site 8651-0, Fuzhou, Fujian
Research Site 8638-0, Xiamen, Fujian
Research Site 8630-0, Lanzhou, Gansu
Research Site 8604-0, Guangzhou, Guangdong
Research Site 8628-0, Guangzhou, Guangdong
Research Site 8621-0, Huizhou, Guangdong
Research Site 8622-0, Zhuhai, Guangdong
Research Site 8615-0, Nanning, Guangxi
Research Site, Baoding, Hebei
Research Site 8629-0, Baoding, Hebei
Research Site 8645-0, Shijiazhuang, Hebei
Research Site 8619-0, Harbin, Heilongjiang
Research Site 8649-0, Anyang, Henan
Research Site 8609-0, Luoyang, Henan
Research Site 8648-0, Weihui, Henan
Research Site 8605-0, Zhengzhou, Henan
Research Site 8623-0, Zhengzhou, Henan
Research Site 8637-0, Wuhan, Hubei
Research Site 8608-0, Wuhan, Hubei
Research Site 8633-0, Xiangyang, Hubei
Research Site 8635-0, Changsha, Hunan
Research Site 8654-0, Yongzhou, Hunan
Research Site 8646-0, Huai'an, Jiangsu
Research Site 8607-0, Nanjing, Jiangsu
Research Site 8624-0, Xuzhou, Jiangsu
Research Site 8631-0, Nanchang, Jiangxi
Research Site 8612-0, Changchun, Jilin
Research Site 8618-0, Changchun, Jilin
Research Site 8644-0, Changchun, Jilin
Research Site 8636-0, Dalian, Liaoning
Research Site-8636-0, Dalian, Liaoning
Research Site 8643-0, Shenyang, Liaoning
Research Site 8642-0, Shenyang, Liaoning
Research Site 8634-0, Jinan, Shandong
Research Site 8613-0, Jining, Shandong
Research Site 8610-0, Linyi, Shandong
Research Site 8650-0, Weihai, Shandong
Research Site 8603-0, Shanghai, Shanghai
Research Site 8602-0, Shanghai, Shanghai
Research Site 8611-0, Xi'an, Shanxi
Research Site 8606-0, Chengdu, Sichuan
Research Site 8626-0, Neijiang, Sichuan
Research Site 8647-0, Zigong, Sichuan
Research Site 8617-0, Tianjin, Tianjin
Research Site 8616-0, Urumqi, Xinjiang
Research Site 8632-0, Kunming, Yunnan
Research Site 8652-0, Hangzhou, Zhejiang
Research Site 8620-0, Hangzhou, Zhejiang
Research Site 8641-0, Hangzhou, Zhejiang
Research Site 3311-0, Marseille cedex 20, Bouches-du-Rhône
Research Site 3303-0, La Rochelle cedex, Charente Maritime
Research Site 3312-0, Besancon Cedex, Doubs
Research Site 3308-0, Nimes, Gard
Research Site 3314-0, Bordeaux, Gironde
Research Site 3305-0, Toulouse cedex 09, Haute Garonne
Research Site 3309-0, Limoges, Haute Vienne
Research Site 3304-0, Montpellier, Herault
Research Site 3310-0, Saint Herblain, Loire Atlantique
Research Site 3301-0, Angers Cedex 2, Maine Et Loire
Research Site 3315-0, Lille cedex, Nord
Research Site 3306-0, Bayonne cedex, Pyrenees Atlantiques
Research Site 3318-0, Pierre Benite cedex, Rhone
Research Site 3313-0, Rouen, Seine Maritime
Research Site 3307-0, Avignon Cedex 9, Vaculuse
Research Site 3302-0, Creteil Cedex, Val De Marne
Research Site 3316-0, Paris, Not set
Research Site 4907-0, Erlangen, Bayern
Research Site 4909-0, Wiesbaden, Hessen
Research Site 4904-0, Bottrop, Nordrhein Westfalen
Research Site 4901-0, Witten, Nordrhein Westfalen
Research Site 4903-0, Dresden, Sachsen
Research Site 4905-0, Berlin, Not set
Research Site 4906-0, Berlin, Not set
Research Site 8504-0, Hong Kong, Not set
Research Site 8501-0, Hong Kong, Not set
Research Site 8503-0, Hong Kong, Not set
Research Site 8502-0, Hong Kong, Not set
Research Site 8505-0, Hong Kong, Not set
Research Site 3603-0, Budapest, Not set
Research Site 3606-0, Gyor, Not set
Research Site 3604-0, Kecskemet, Not set
Research Site 3602-0, Salgotarjan, Not set
Research Site 3607-0, Tatabanya, Not set
Research Site 3605-0, Zalaegerszeg, Not set
Research Site 9710-0, Ashdod, Not set
Research Site 9706-0, Haifa, Not set
Research Site 9708-0, Haifa, Not set
Research Site 9702-0, Jerusalem, Not set
Research Site 9707-0, Jerusalem, Not set
Research Site 9703-0, Kfar-Saba, Not set
Research Site 9704-0, Petach-Tikva, Not set
Research Site 9709-0, Ramat-Gan, Not set
Research Site 9705-0, Rehovot, Not set
Research Site 9701-0, Tel Aviv, Not set
Research Site 3908-0, Bergamo, Not set
Research Site 3907-0, Brescia, Not set
Research Site 3901-0, Catania, Not set
Research Site 3903-0, Catanzaro, Not set
Research Site 3906-0, Milano, Not set
Research Site 3911-0, Milano, Not set
Research Site 3904-0, Milano, Not set
Research Site 3909-0, Napoli, Not set
Research Site 3902-0, Pavia, Not set
Research Site 3905-0, Verona, Not set
Research Site 8211-0, Wonju, Gangwon-do
Research Site 8204-0, Seongnam, Gyeonggi-do
Research Site 8201-0, Seoul, Gyeonggi-do
Research Site 8202-0, Suwon, Gyeonggi-do
Research Site 8208-0, Busan, Not set
Research Site 8212-0, Cheonan, Not set
Research Site 8209-0, Incheon, Not set
Research Site 8207-0, Seoul, Not set
Research Site 8213-0, Seoul, Not set
Research Site 8206-0, Seoul, Not set
Research Site 8210-0, Seoul, Not set
Research Site 8203-0, Seoul, Not set
Research Site 8205-0, Seoul, Not set
Research Site 8214-0, Ulsan, Not set
Research Site 4804-0, Krakow, Not set
Research Site 4801-0, Poznan, Not set
Research Site 4802-0, Rzeszów, Not set
Research Site 4807-0, Torun, Not set
Research Site 4805-0, Warszawa, Not set
Research Site 4809-0, Wroclaw, Not set
Research Site 4803-0, Łódź, Not set
Research Site 3403-0, Sant Cugat del Valles, Barcelona
Research Site 3409-0, Santiago de Compostela, La Coruña
Research Site 3406-0, Majadahonda, Madrid
Research Site 3411-0, Pozuelo de Alarcon, Madrid
Research Site 3405-0, Pamplona, Navarra
Research Site 3410-0, Barcelona, Not set
Research Site 3402-0, Barcelona, Not set
Research Site 3404-0, Barcelona, Not set
Research Site 3416-0, Madrid, Not set
Research Site 3407-0, Madrid, Not set
Research Site 3414-0, Madrid, Not set
Research Site 3401-0, Madrid, Not set
Research Site 3418-0, Malaga, Not set
Research Site 3415-0, Málaga, Not set
Research Site 3408-0, Sevilla, Not set
Research Site 3413-0, Sevilla, Not set
Research Site 3417-0, Sevilla, Not set
Research Site 3412-0, Valencia, Not set
Research Site 9001-0, Adana, Not set
Research Site 9002-0, Ankara, Not set
Research Site 9006-0, Ankara, Not set
Research Site 9003-0, Ankara, Not set
Research Site 9004-0, Ankara, Not set
Research Site 9009-0, Diyarbakir, Not set
Research Site 9008-0, Istanbul, Not set
Research Site 9010-0, Izmir, Not set
Research Site 9007-0, Samsun, Not set
Research Site 4404-0, Truro, Cornwall
Research Site 4408-0, London, Greater London
Research Site 4411-0, London, Greater London
Research Site 4406-0, London, Greater London
Research Site 4416-0, London, Greater London
Research Site 4409-0, London, Greater London
Research Site 4402-0, Manchester, Greater Manchester
Research Site 4415-0, Maidstone, Kent
Research Site 4414-0, Bath, Somerset
Research Site 4410-0, Cardiff, South Glamorgan
Research Site 4405-0, Glasgow, Strathclyde
Research Site 4416-A, Sutton, Surrey
Research Site 4407-0, Leeds, West Yorkshire
Research Site 4403-0, Middlesex, Not set
Research Site 4401-0, Nottingham, Not set
Conditions: Metastatic Breast Cancer
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Recruiting
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation.
The main quest... Read More
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation.
The main question the study aims to answer is:
• To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/30/2025
Locations: Mayo Clinic - Phoenix, Phoenix, Arizona +173 locations
Mayo Clinic - Phoenix, Phoenix, Arizona
University of Arizona - Cancer Center, Tucson, Arizona
Providence Medical Foundation - Santa Rosa, CA, Santa Rosa, California
Mayo Clinic - Jacksonville, Jacksonville, Florida
Miami Cancer Institute, Miami, Florida
Miami Cancer Institute Plantation, Plantation, Florida
Emory University School of Medicine, Atlanta, Georgia
Norton Cancer Institute, Louisville, Kentucky
Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland
Massachusetts General Hospital, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan
Allina Health System DBA Virginia Piper Cancer Institute, Minneapolis, Minnesota
Mayo Clinic - Rochester, Rochester, Minnesota
Saint Luke's Cancer Institute, Kansas City, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Renown Regional Medical Centre, Reno, Nevada
New Jersey Cancer Care, PA, Belleville, New Jersey
The Blavatnik Family - Chelsea Medical Center at Mount Sinai, New York, New York
Icahn School of Medicine at Mount Sinai, New York, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York
Duke University Medical Center, Durham, North Carolina
Altru Health Systems, Grand Forks, North Dakota
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James), Columbus, Ohio
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Lyndon B. Johnson Hospital, Houston, Texas
Baylor College of Medicine, Houston, Texas
MD Anderson Cancer Center, Houston, Texas
Harris Health System - Smith Clinic, Houston, Texas
Blacktown Hospital, Blacktown, Not set
Concord Repatriation General Hospital, Concord, Not set
Mater Misericordiae Ltd, South Brisbane, South Brisbane, Not set
Cliniques Universitaires Saint-Luc, Brussels, Not set
Antwerp University Hospital (UZA), Edegem, Not set
Universitaire Ziekenhuizen Leuven, Leuven, Not set
CHU UCL Namur - Site De Sainte-Elisabeth, Namur, Not set
The Ottawa General Hospital, Ottawa, Ontario
Sunnybrook Health Sciences Centre -Bayview Campus, Toronto, Ontario
Hospital Maisonneuve-Rosemont, Montréal, Quebec
Lady Davis Institute for Medical Research Jewish General Hospital, Montréal, Quebec
CIUSSS du Saguenay-Lac-Saint-Jean, Saguenay, Quebec
Anhui Provincial Cancer Hospital, Anhui, Not set
Beijing Cancer Hospital, Beijing, Not set
The First Affiliated Hospital of Bengbu Medical University, Bengbu, Not set
The First Hospital of Jilin University, Changchun, Not set
The Second Xiangya Hospital of Central South University, Changsha, Not set
Sichuan Provincial People's Hospital, Chengdu, Not set
West China Hospital, Sichuan University, Chengdu, Not set
The First Affiliated Hospital, Chongqing Medical University, Chongqi, Not set
The Second Hospital of Dalian Medical University, Dalian, Not set
Deyang People's Hospital, Deyang, Not set
Fuyang Cancer Hosptial, Fuyang, Not set
Fujian Cancer Hospital, Fuzhou, Not set
Fujian Medical University Union Hospital, Fuzhou, Not set
Zhujiang Hospital of Nanfang Medical University, Guandong, Not set
Guangdong Provincial People's Hospital, Guangdong, Not set
Meizhou People's Hospital, Guangdong, Not set
Peking University Shenzhen Hospital, Guangdong, Not set
Sun Yat-Sen University- Cancer Center, Guangdong, Not set
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Not set
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Not set
Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Not set
Hebei Medical University - The Fourth Hospital - Hebei Provincial Tumor Hospital, Hebei, Not set
Xiangyang Central Hospital, Hubei, Not set
Xiangya Hospital Central South University, Hunan, Not set
Shandong Province Tumor Hospital, Jinan, Not set
Gansu Provincial Hospital, Lanzhou, Not set
The First Hospital of Lanzhou University, Lanzhou, Not set
Linyi Cancer Hospital, Linyi, Not set
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Not set
The Affiliated Hospital of Southwest Medical University (Luzhou Medical College), Luzhou, Not set
Jiangxi Cancer Hospital, Nanchang, Not set
Nangchang People's Hospital, Nanchang, Not set
Nanjing Drum Tower Hospital, Nanjing, Not set
Guangxi Medical University Cancer Hospital, Nanning, Not set
Nanyang Central Hospital, Nanyang, Not set
The Second People's Hospital of Neijiang, Neijiang, Not set
Ningbo Medical Center Li Huili Hospital, Ningbo, Not set
Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Not set
The Affiliated Hospital of Qingdao University, Qingdao, Not set
Fudan University Cancer Center, Shang'ai, Not set
First Affiliated Hospital of Xi'an Jiaotong University, Shanxi, Not set
The Central Hospital of Shaoyang, Shaoyang, Not set
Liaoning Cancer Hospital & Institute, Shenyang, Not set
Yuebei People's Hospital, Shouguang, Not set
University of Electonic Science & Technology (UESTC) - Sichuan Cancer Hospital & Institute, Sichuan, Not set
Tianjin Cancer Hospital Airport Hospital, Tianjin, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set
Hubei Cancer Hospital, Wuhan, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technolog, Wuhan, Not set
The First Affiliated Hospital of Air Force Medical University, XI Ail, Not set
The first affiliated hospital of Xiamen University, Xiamen, Not set
Xuzhou Central Hospital, Xuzhou, Not set
Yuncheng Central Hospital, Yuncheng, Not set
Zhejiang cancer hospital, Zhejiang, Not set
Zhejiang Provincial People's Hospital, Zhejiang, Not set
Henan Cancer Hospital, Zhengzhou, Not set
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Not set
Zhongshan City People's Hospital, Zhongshan, Not set
Zhumadian Central Hospital, Zhumadian, Not set
The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, Not set
Service d'Oncologie Medicale - CHRU Besancon, Besançon, Not set
Institut Bergonie, Bordeaux, Not set
Centre Francois Baclesse, CAEN Cedex 05, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon, Not set
Institut Paoli-Calmettes, Marseille, Not set
CHU Poitiers - Pole Regional de Cancerologie de Poitiers (PRC), Poitiers, Not set
Centre Henri Becquerel, Rouen, Not set
Institut Claudius Regaud, Toulouse, Not set
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Not set
Klinikum rechts der Isar der Technischen Universitaet Muenchen, München, Not set
Rambam Health Care Campus, Haifa, Not set
Hadassah Ein-Karem Medical Center, Jerusalem, Not set
Shaare Zedek Medical Center, Jerusalem, Not set
Rabin MC, Petach Tikva, Not set
Kaplan Medical Center, Reẖovot, Not set
Tel Aviv Sourasky Medical Center, Tel Aviv, Not set
Sheba Medical Center, Tel HaShomer, Not set
Centro Riferimento Oncologico - Aviano, Aviano, Not set
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l., Meldola, Not set
Istituto Europeo di Oncologia, Milano, Not set
Humanitas Istituto Clinico Catanese, Misterbianco, Not set
Azienda Ospedaliero-Universitaria di Modena, Modena, Not set
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Not set
Azienda Ospedaliero Universitaria di Parma, Parma, Not set
Fondazione IRCCS Policlinico San Matteo, Pavia, Not set
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma, Not set
Azienda Ospedaliera Universitaria Integrata Verona-Ospedale Borgo Trento, Verona, Not set
National Cancer Center, Gyeonggi-do, Not set
Chonnam National University Hwasun Hospital, Hwasun, Not set
Asan Medical Center, Seoul, Not set
Korea University Anam Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
KO - MED Centra Kliniczne Sp. z o.o., Wojewodzki Szpital Specjalistyczny w Bialej Podlaskiej, Biała Podlaska, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Oddzial w Gliwicach, I Klinika Radioterapii i Chemioterapii, Gliwice, Not set
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie - Oddzial Onkologii Klinicznej z Pododdzialem Dziennym, Krakow, Not set
SP ZOZ Szpital Uniwersytecki w Krakowie, Oddzial Onkologii Klinicznej, Kraków, Not set
Uniwersytecki Szpital Kliniczny w Poznaniu, Oddzial Chemioterapii, Poznań, Not set
Wielkopolskie Centrum Onkologii (WCO) / The Greater Poland Cancer Center, Poznań, Not set
Mazowiecki Szpital Onkologiczny, Wieliszew, Not set
Instytut Centrum Zdrowia Matki Polki - Klinika Onkologii, Łódź, Not set
Centrul Medical Focus, Bucharest, Not set
Radiotherapy Center Cluj, Cluj-Napoca, Not set
Onco Clinic Consult SA, Craiova, Not set
Oncology Center Sfantul Nectarie, Craiova, Not set
Gral Medical SRL, Piteşti, Not set
OncoMed Oncology Center, Timişoara, Not set
National Cancer Centre Singapore, Singapore, Not set
Curie Oncology, Singapore, Not set
Hospital Clinic Barcelona, Barcelona, Not set
Hospital Universitario Vall d'Hebron, Barcelona, Not set
Hospital Universitario Reina Sofia, Córdoba, Not set
Clinica Universidad de Navarra - Madrid, Madrid, Not set
Hospital Beata Maria Ana, Madrid, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario de La Princesa, Madrid, Not set
Hospital Regional Universitario de Malaga, Málaga, Not set
Clinica Universidad de Navarra - Pamplona, Pamplona, Not set
Instituto Valenciano de Oncologia, Valencia, Not set
Changhua Christian Hospital (CCH), Changhua, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Tri-Service General Hospital, Taipei City, Not set
Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Not set
National Taiwan University Hospital, Taipei, Not set
Linkou Chang Gung Memorial Hospital (CGMHLK), Taoyuan City, Not set
Leeds Teaching Hospitals NHS Trust, Leeds, Not set
Charing Cross Hospital, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Nottingham City Hospital, Nottingham, Not set
Conditions: Metastatic Breast Cancer
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting
This phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in combination with a CDK4/6 inhibitor.
This phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in combination with a CDK4/6 inhibitor. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/23/2025
Locations: Clinical Trial Site, Tucson, Arizona +173 locations
Clinical Trial Site, Tucson, Arizona
Clinical Trial Site, Fountain Valley, California
Clinical Trial Site, La Jolla, California
Clinical Trial Site, Los Angeles, California
Clinical Trial Site, Whittier, California
Clinical Trial Site, Aurora, Colorado
Clinical Trial Site, Denver, Colorado
Clinical Trial Site, Golden, Colorado
Clinical Trial Site, Grand Junction, Colorado
Clinical Trial Site, Danbury, Connecticut
Clinical Trial Site, Newark, Delaware
Clinical Trials Site, Jacksonville, Florida
Clinical Trial Site, Margate, Florida
Clinical Trial Site, Orlando, Florida
Clinical Trial Site, Plantation, Florida
Clinical Trial Site, Tamarac, Florida
Clinical Trial Site, Atlanta, Georgia
Clinical Trial Site, Chicago, Illinois
Clinical Trial Site, Chicago, Illinois
Clinical Trial Site, Urbana, Illinois
Clinical Trial Site, Baton Rouge, Louisiana
Clinical Trial Site, Baltimore, Maryland
Clinical Trial Site, Boston, Massachusetts
Clinical Trial Site, St Louis Park, Minnesota
Clinical Trial Site, Lincoln, Nebraska
Clinical Trial Site, Farmington, New Mexico
Clinical Trial Site, New York, New York
Clinical Trial Site, Port Jefferson Station, New York
Clinical Trial Site, Dayton, Ohio
Clinical Trial Site, Toledo, Ohio
Clinical Trial Site, Portland, Oregon
Clinical Trial Site, Nashville, Tennessee
Clinical Trial Site, Nashville, Tennessee
Clinical Trial Site, Dallas, Texas
Clinical Trial Site, Dallas, Texas
Clinical Trial Site, Houston, Texas
Clinical Trial Site, Spokane, Washington
Clinical Trial Site, Spokane, Washington
Clinical Trial Site, San Salvador De Jujuy, Jujuy
Clinical Trial Site, Viedma, Río Negro
Clinical Trial Site, Rosario, Santa Fe
Clinical Trial Site, Rosario, Santa Fe
Clinical Trial Site, San Miguel De Tucumán, Tucumán
Clinical Trial Site, Buenos Aires, Not set
Clinical Trial Site, Córdoba, Not set
Clinical Trial Site, Córdoba, Not set
Clinical Trial Site, La Rioja, Not set
Clinical Trial Site, Gosford, New South Wales
Clinical Trial Site, Westmead, New South Wales
Clinical Trial Site, Adelaide, South Australia
Clinical Trial Site, Ballarat Central, Victoria
Clinical Trial Site, Clayton, Victoria
Clinical Trial Site, Shepparton, Victoria
Clinical Trial Site, Nedlands, Western Australia
Clinical Trial Site, Edegem, Antwerpen
Clinical Trial Site, Woluwe-Saint-Lambert, Brussels
Clinical Trial Site, Charleroi, Hainaut
Clinical Trial Site, Leuven, Vlaams Brabant
Clinical Trial Site, Salvador, Bahia
Clinical Trial Site, Belo Horizonte, Minas Gerais
Clinical Trial Site, Recife, Pernambuco
Clinical Trial Site, Porto Alegre, Rio Grande do Sul
Clinical Trial Site, Porto Alegre, Rio Grande do Sul
Clinical Trial Site, Itajaí, Santa Catarina
Clinical Trial Site, Sorocaba, São Paulo
Clinical Trial Site, Rio De Janeiro, Not set
Clinical Trial Site, Panagyurishte, Pazardzhik
Clinical Trial Site, Sofia, Sofia-Grad
Clinical Trial Site, Vratsa, Not set
Clinical Trial Site, Calgary, Alberta
Clinical Trial Site, Montréal, Quebec
Clinical Trial Site, Hradec Králové, Královéhradecký kraj
Clinical Trial Site, Nový Jičín, Moravskoslezský kraj
Clinical Trial Site, Olomouc, Olomoucký kraj
Clinical Trial Site, Bourg-en-Bresse, Ain
Clinical Trial Site, Besançon, Doubs
Clinical Trial Site, Nantes, Loire-Atlantique
Clinical Trial Site, Compiègne, Oise
Clinical Trial Site, Clermont-Ferrand, Puy-de-Dôme
Clinical Trial Site, Le Mans, Sarthe
Clinical Trial Site, Villejuif, Val-de-Marne
Clinical Trial Site, Montpellier, Not set
Clinical Trial Site, Karlsruhe, Baden-Württemberg
Clinical Trial Site, Krefeld, Nordrhein-Westfalen
Clinical Trial Site, Velbert, Nordrhein-Westfalen
Clinical Trial Site, Dresden, Sachsen
Clinical Trial Site, Central, Not set
Clinical Trial Site, Central, Not set
Clinical Trial Site, Hong Kong, Not set
Clinical Trials Site, Hong Kong, Not set
Clinical Trial Site, Kowloon, Not set
Clinical Trial Site, Pécs, Baranya
Clinical Trial Site, Kecskemét, Bács-Kiskun
Clinical Trial Site, Debrecen, Hajdú-Bihar
Clinical Trial Site, Avellino, Campania
Clinical Trial Site, Bologna, Emilia-Romagna
Clinical Trial Site, Meldola, Emilia-Romagna
Clinical Trial Site, Modena, Emilia-Romagna
Clinical Trial Site, Reggio Emilia, Emilia-Romagna
Clinical Trial Site, Udine, Friuli-Venezia Giulia
Clinical Trial Site, Roma, Lazio
Clinical Trial Site, Roma, Lazio
Clinical Trial Site, Milano, Lombardia
Clinical Trial Site, Rozzano, Lombardia
Clinical Trial Site, Alessandria, Piemonte
Clinical Trial Site, Pavia, Not set
Clinical Trial Site, Suwon-si, Gyeonggi-do
Clinical Trial Site, Busan, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Seoul, Not set
Clinical Trial Site, Suwon, Not set
Clinical Trials Site, Sungai Petani, Kedah
Clinical Trial Site, Kota Bharu, Kelantan
Clinical Trial Site, George Town, Penang
Clinical Trial Site, Ipoh, Perak
Clinical Trial Site, Putrajaya, Putramya
Clinical Trial Site, Kuching, Sarawak
Clinical Trial Site, Petaling Jaya, Selangor
Clinical Trial Site, Kuala Lumpur, WP
Clinical Trial Site, Zapopan, Jalisco
Clinical Trial Site, Monterrey, Not set
Clinical Trial Site, Oaxaca, Not set
Clinical Trial Site, Sinaloa, Not set
Clinical Trial Site, Rotterdam, Zuid-Holland
Clinical Trial Site, Łódź, Lódzkie
Clinical Trial Site, Otwock, Mazowieckie
Clinical Trial Site, Brzozów, Podkarpackie
Clinical Trial Site, Rzeszów, Podkarpackie
Clinical Trial Site, Gdynia, Pomorskie
Clinical Trial Site, Skórzewo, Wielkopolskie
Clinical Trial Site, Wrocław, Not set
Clinical Trial Site, Matosinhos, Porto
Clinical Trial Site, Coimbra, Not set
Clinical Trial Site, Lisboa, Not set
Clinical Trial Site, Lisboa, Not set
Clinical Trial Site, Porto, Not set
Clinical Trial Site, Mayaguez, Not set
Clinical Trial Site, Oradea, Bihor
Clinical Trial Site, București, Bucuresti
Clinical Trial Site, Cluj-Napoca, Cluj
Clinical Trial Site, Craiova, Dolj
Clinical Trial Site, Timisoara, Timis
Clinical Trial Site, Brașov, Not set
Clinical Trial Site, Iași, Not set
Clinical Trial Site, Pamplona, Navarra
Clinical Trial Site, Alicante, Not set
Clinical Trial Site, Badajoz, Not set
Clinical Trial Site, León, Not set
Clinical Trial Site, Lleida, Not set
Clinical Trial Site, Madrid, Not set
Clinical Trial Site, Madrid, Not set
Clinical Trial Site, Santiago De Compostela, Not set
Clinical Trial Site, Valencia, Not set
Clinical Trial Site, Changhua, Not set
Clinical Trial Site, Kaohsiung, Not set
Clinical Trial Site, Taichung, Not set
Clinical Trial Site, Taichung, Not set
Clinical Trial Site, Tainan City, Not set
Clinical Trial Site, Taipei city, Not set
Clinical Trial Site, Taipei city, Not set
Clinical Trial Site, Taipei, Not set
Clinical Trial Site, Taipei, Not set
Clinical Trial Site, Bangkok, Not set
Clinical Trial Site, Bangkok, Not set
Clinical Trial Site, Bangkok, Not set
Clinical Trial Site, Chiang Mai, Not set
Clinical Trial Site, Samut Sakhon, Not set
Clinical Trial Site, Songkhla, Not set
Clinical Trial Site, London, Not set
Conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
Recruiting
The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual.
The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/17/2025
Locations: Sunnybrook Health Sciences Centre, Toronto, Ontario
Sunnybrook Health Sciences Centre, Toronto, Ontario
1 - 8 of 8